Cargando cotizaciones...
Previsión
| Comprar |
1 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
Capstone Energy+ increases production for data centers and expands manufacturing capacity
Capstone Energy+ reports rising demand from data centers and has expanded manufacturing in Van Nuys from 2 MW to 7 MW per week in single‑shift operation; in two shifts annual capacity could exceed 700 MW. The company highlights its low‑maintenance turbine design, is working on 800‑V‑DC compatibility, lower emissions, a restart of the C250 engine, and a roadmap to 500 kW/1 MW systems. Capstone sees near‑term growth in data centers but also aims to address ports, utilities and substations and is focusing on KWK/KWKK with high heat‑recovery efficiency. After an earlier Chapter‑11 proceeding, management is working with Monarch to clean up the capital structure and expects improvements within about six months. » Más en de.investing.com
Capstone secures $10 million convertible note to finance acquisitions
Capstone Holding Corp. has secured a $10 million convertible note facility to fund its acquisition strategy and drive growth. The first tranche of $3 million will be used to acquire a distributor in the southeastern United States, while the company reaffirms its financial targets for 2025. CEO Matt Lipman highlights the flexibility of the financing and the goal to increase revenue to $100 million. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | junio de 2026 | |
|---|---|---|
| Ingresos | 18,82 M | 72,61 % |
| Beneficio bruto | 5,26 M | 97,94 % |
| Beneficio neto | -1,21 M | 103,60 % |
| EBITDA | 2,31 M | 1964,62 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 2,32 M € |
Número de acciones | 15,2 M |
Máximo/mínimo de 52 semanas | 1,31 € - 0,15 € |
| Dividendos | No |
Beta | -1,50 |
Ratio P/E | -0,05 |
Ratio PEG | 0,00 |
Ratio P/B | 0,18 |
Ratio P/S | 0,04 |
Perfil de la empresa
Capstone Therapeutics Corp. ist ein Biotechnologieunternehmen, das neuartige Peptide und andere Moleküle zur Unterstützung von Patienten mit unterversorgten Krankheiten in den Vereinigten Staaten entwickelt. Es entwickelt das Apo-E-mimetische Peptidmolekül AEM-28 und seine Analoga, die klinische Studien der Phase Ia und der Phase Ib/IIa für den Lipoproteinstoffwechsel abgeschlossen haben. Das Unternehmen war früher als OrthoLogic Corp. bekannt und änderte im Mai 2010 seinen Namen in Capstone Therapeutics Corp. Capstone Therapeutics Corp. wurde 1987 gegründet und hat seinen Hauptsitz in Tempe, Arizona.
| Nombre | CAPSTONE THERAP. DL-,0005 |
| CEO | Matthew E. Lipman |
| Sede | Alsip,
il Estados Unidos |
| Sitio web | |
| Salida a bolsa | 28/01/1993 |
| Empleados | 93 |
Deep Dive
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
Pnk | CAPS |